OBJECTIVE	The purpose of this study was to determine whether combined treatment with a selective serotonin reuptake inhibitor ( SSRI ) and a norepinephrine reuptake inhibitor , desipramine , effectively reduces obsessive-compulsive symptoms in patients who do not respond to SSRIs .\